Antigua and Barbuda vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB

Antigua and Barbuda
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Antigua and Barbuda rank
1st
Western Pacific (WHO region) rank
2nd

New cases tested for RR-/MDR-TB over time

  • Antigua and Barbuda
  • Western Pacific (WHO region)
020406080100200520142024

How they compare

Antigua and Barbuda currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.

That makes Antigua and Barbuda's figure about 1.1 times Western Pacific (WHO region)'s.

The two have swapped places 1 time across 12 shared years of data; in 2009 it was Western Pacific (WHO region) ahead.

Antigua and Barbuda ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.

Western Pacific (WHO region) has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Antigua and Barbuda Western Pacific (WHO region) Difference Ahead
2000s 0.0% 0.6% 0.6% Western Pacific (WHO region)
2010s 0.0% 18.9% 18.9% Western Pacific (WHO region)
2020s 33.3% 81.3% 48.0% Western Pacific (WHO region)

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Antigua and Barbuda or Western Pacific (WHO region)?
Antigua and Barbuda, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
What is the difference in new cases tested for rr-/mdr-tb between Antigua and Barbuda and Western Pacific (WHO region)?
11.0%, with Antigua and Barbuda ahead.
How many years of comparable data are there for Antigua and Barbuda and Western Pacific (WHO region)?
12 years are reported by both, from 2009 to 2024.
How do Antigua and Barbuda and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
Antigua and Barbuda ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Antigua and Barbuda vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/antigua-and-barbuda/western-pacific-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/antigua-and-barbuda/western-pacific-who-region/">Antigua and Barbuda vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed